Market Tracker

10/24 6:05pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.29
Data as of Oct 24
 -0.02 / -0.87%
Today’s Change
2.05
Today|||52-Week Range
5.30
-41.13%
Year-to-Date

Today’s Trading

Previous close2.31
Today’s open2.34
Day’s range2.26 - 2.38
Volume199,814
Average volume (3 months)459,014
Market cap$214.5M
Dividend yield--
Data as of 4:02pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BPTHBio-Path Holdings In...-0.01-0.41%
QUREUniqure NV+0.18+1.57%
PSTIPluristem Therapeuti...+0.01+0.34%
NSTGNanoString Technolog...-0.07-0.66%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts